{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T16:46:37Z","timestamp":1790959597548,"version":"4.1.0"},"reference-count":184,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100003593","name":"National Council for Scientific and Technological Development","doi-asserted-by":"publisher","award":["302689\/2020-6"],"award-info":[{"award-number":["302689\/2020-6"]}],"id":[{"id":"10.13039\/501100003593","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004809","name":"Financiadora de Estudos e Projetos","doi-asserted-by":"publisher","award":["3348\/2022"],"award-info":[{"award-number":["3348\/2022"]}],"id":[{"id":"10.13039\/501100004809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002322","name":"Coordena\u00e7\u00e3o de Aperfei\u00e7oamento de Pessoal de N\u00edvel Superior","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100002322","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001807","name":"Funda\u00e7\u00e3o de Amparo \u00e0 Pesquisa do Estado de S\u00e3o Paulo","doi-asserted-by":"publisher","award":["2024\/05739-6"],"award-info":[{"award-number":["2024\/05739-6"]}],"id":[{"id":"10.13039\/501100001807","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001807","name":"Funda\u00e7\u00e3o de Amparo \u00e0 Pesquisa do Estado de S\u00e3o Paulo","doi-asserted-by":"publisher","award":["2023\/05739-6"],"award-info":[{"award-number":["2023\/05739-6"]}],"id":[{"id":"10.13039\/501100001807","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Bioorganic Chemistry"],"published-print":{"date-parts":[[2024,12]]},"DOI":"10.1016\/j.bioorg.2024.107914","type":"journal-article","created":{"date-parts":[[2024,11,5]],"date-time":"2024-11-05T18:09:15Z","timestamp":1730830155000},"page":"107914","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":14,"special_numbering":"C","title":["Advances in drug discovery of flavivirus NS2B-NS3pro serine protease inhibitors for the treatment of Dengue, Zika, and West Nile viruses"],"prefix":"10.1016","volume":"153","author":[{"given":"Em\u00edlio Em\u00edlio","family":"Jo\u00e3o","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juliana Romano","family":"Lopes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bruna Fernanda Rodrigues","family":"Guedes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paulo Ricardo","family":"da Silva Sanches","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chung Man","family":"Chin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean Leandro","family":"dos Santos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cau\u00ea Benito","family":"Scarim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bioorg.2024.107914_b0005","first-page":"291","article-title":"Emerging and reemerging viral diseases","author":"Louten","year":"2016","journal-title":"Essential Human Virology"},{"key":"10.1016\/j.bioorg.2024.107914_b0010","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1097\/QCO.0000000000000729","article-title":"Arboviral central nervous system infections","volume":"34","author":"Schultz","year":"2021","journal-title":"Curr. Opin. Infect. Dis."},{"key":"10.1016\/j.bioorg.2024.107914_b0015","doi-asserted-by":"crossref","unstructured":"Y.D. Gwon, M. Strand, R. Lindqvist, E. Nilsson, M. Saleeb, M. Elofsson, A. K. Overby, \u00a8 M. Evander, Viruses, Antiviral Activity of Benzavir-2 against Emerging Flaviviruses, Viruses 12 (2020) 351, https:\/\/doi.org\/10.3390\/v12030351.","DOI":"10.3390\/v12030351"},{"key":"10.1016\/j.bioorg.2024.107914_b0020","doi-asserted-by":"crossref","first-page":"223","DOI":"10.4172\/2329-891X.1000223","article-title":"Aedes aegypti as a vector of flavivirus","volume":"4","author":"Muktar","year":"2016","journal-title":"J. Trop Dis."},{"key":"10.1016\/j.bioorg.2024.107914_b0025","doi-asserted-by":"crossref","first-page":"158","DOI":"10.3390\/insects9040158","article-title":"Effects of the environmental temperature on Aedes aegypti and Aedes albopictus mosquitoes: a review","volume":"9","author":"Reinhold","year":"2018","journal-title":"Insects"},{"key":"10.1016\/j.bioorg.2024.107914_b0030","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/j.antiviral.2016.03.010","article-title":"Zika virus: history, emergence, biology, and prospects for control","volume":"130","author":"Weaver","year":"2016","journal-title":"Antivir. Res."},{"key":"10.1016\/j.bioorg.2024.107914_b0035","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1128\/CMR.00072-15","article-title":"Zika virus","volume":"29","author":"Musso","year":"2016","journal-title":"Clin. Microbiol. Rev."},{"key":"10.1016\/j.bioorg.2024.107914_b0040","doi-asserted-by":"crossref","first-page":"O595","DOI":"10.1111\/1469-0691.12707","article-title":"Rapid spread of emerging Zika virus in the Pacific area","volume":"20","author":"Musso","year":"2014","journal-title":"Clin. Microbiol. Infect."},{"key":"10.1016\/j.bioorg.2024.107914_b0045","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1016\/S0140-6736(16)00257-9","article-title":"Concern over Zika virus grips the world","volume":"387","author":"Samarasekera","year":"2016","journal-title":"Lancet"},{"key":"10.1016\/j.bioorg.2024.107914_b0050","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/j.virusres.2018.07.018","article-title":"Drug repurposing of quinine as antiviral against dengue virus infection","volume":"255","author":"Malakar","year":"2018","journal-title":"Virus Res."},{"key":"10.1016\/j.bioorg.2024.107914_b0055","doi-asserted-by":"crossref","first-page":"e0006618","DOI":"10.1371\/journal.pntd.0006618","article-title":"Dengue infection in India: a systematic review and meta-analysis","volume":"12","author":"Ganeshkumar","year":"2018","journal-title":"PLoS Neglected Trop. Dis."},{"key":"10.1016\/j.bioorg.2024.107914_b0060","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1038\/nature12060","article-title":"The global distribution and burden of dengue","volume":"496","author":"Bhatt","year":"2013","journal-title":"Nature"},{"key":"10.1016\/j.bioorg.2024.107914_b0065","unstructured":"World Health Organization (WHO), Dengue and severe dengue. https:\/\/www.who.int\/health-topics\/dengue-and-severe-dengue#tab=tab_1. (Accessed 1 February 2024)."},{"key":"10.1016\/j.bioorg.2024.107914_b0070","doi-asserted-by":"crossref","first-page":"796","DOI":"10.1038\/s41564-020-0714-0","article-title":"The continued threat of emerging flaviviruses","volume":"5","author":"Pierson","year":"2020","journal-title":"Nat. Microbiol."},{"key":"10.1016\/j.bioorg.2024.107914_b0075","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1016\/j.tim.2013.12.011","article-title":"Global spread of dengue virus types: mapping the 70 year history","volume":"22","author":"Messina","year":"2014","journal-title":"Trends Microbiol."},{"key":"10.1016\/j.bioorg.2024.107914_b0080","unstructured":"Centers for Disease Control and Prevention (CDC), Yellow fever virus. https:\/\/www.cdc.gov\/yellowfever\/index.html. (Accessed 1 February 2024)."},{"key":"10.1016\/j.bioorg.2024.107914_b0085","unstructured":"Centers for Disease Control and Prevention (CDC), Japonese encephalitis virus. https:\/\/www.cdc.gov\/japaneseencephalitis\/index.html. (Accessed 1 February 2024)."},{"key":"10.1016\/j.bioorg.2024.107914_b0090","unstructured":"Centers for Disease Control and Prevention (CDC), Tick-borne encephalitis (TBE). https:\/\/www.cdc.gov\/tick-borne-encephalitis\/index.html. (Accessed 1 February 2024)."},{"key":"10.1016\/j.bioorg.2024.107914_b0095","unstructured":"Centers for Disease Control and Prevention (CDC), St. Louis encephalitis virus. https:\/\/www.cdc.gov\/sle\/index.html#:\u223c:text=Print-,St.,nausea%2C%20vomiting%2C%20and%20tiredness. (Accessed 1 February 2024)."},{"key":"10.1016\/j.bioorg.2024.107914_b0100","doi-asserted-by":"crossref","first-page":"4448","DOI":"10.1021\/acs.chemrev.7b00719","article-title":"Biochemistry and Molecular Biology of Flaviviruses","volume":"118","author":"Barrows","year":"2018","journal-title":"Chem. Rev."},{"key":"10.1016\/j.bioorg.2024.107914_b0105","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1016\/j.tim.2016.01.002","article-title":"RNA Structure Duplications and Flavivirus Host Adaptation","volume":"24","author":"Villordo","year":"2016","journal-title":"Trends Microbiol."},{"key":"10.1016\/j.bioorg.2024.107914_b0110","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1038\/s41594-017-0010-8","article-title":"Structural Biology of Zika Virus and Other Flaviviruses","volume":"25","author":"Hasan","year":"2018","journal-title":"Nat. Struct. Mol. Biol."},{"key":"10.1016\/j.bioorg.2024.107914_b0115","series-title":"Virus Taxonomy Classification and Nomenclature of Viruses Ninth Report of the International Committee on Taxonomy of Viruses","author":"King","year":"2012"},{"key":"10.1016\/j.bioorg.2024.107914_b0120","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1016\/j.bbrc.2017.01.041","article-title":"Sequence, Structure and Function Relationships in Flaviviruses as Assessed by Evolutive Aspects of Its Conserved Non-Structural Protein Domains","volume":"492","author":"da Fonseca Jr","year":"2017","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.bioorg.2024.107914_b0125","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1016\/j.antiviral.2013.03.008","article-title":"The Flavivirus NS1 Protein: Molecular and Structural Biology, Immunology, Role in Pathogenesis and Application as a Diagnostic Biomarker","volume":"98","author":"Muller","year":"2013","journal-title":"Antivir. Res."},{"key":"10.1016\/j.bioorg.2024.107914_b0130","doi-asserted-by":"crossref","first-page":"e1688","DOI":"10.1002\/wrna.1688","article-title":"Conserved Motifs in the Flavivirus NS3 RNA Helicase Enzyme","volume":"13","author":"Du Pont","year":"2022","journal-title":"Wiley Interdiscip. Rev. RNA"},{"key":"10.1016\/j.bioorg.2024.107914_b0135","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1186\/s13567-021-00966-2","article-title":"Structure and Function of Capsid Protein in Flavivirus Infection and Its Applications in the Development of Vaccines and Therapeutics","volume":"52","author":"Zhang","year":"2021","journal-title":"Vet. Res."},{"key":"10.1016\/j.bioorg.2024.107914_b0140","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1038\/nrmicro1067","article-title":"A structural perspective of the flavivirus life cycle","volume":"3","author":"Mukhopadhyay","year":"2005","journal-title":"Nat. Rev. Microbiol."},{"key":"10.1016\/j.bioorg.2024.107914_b0145","doi-asserted-by":"crossref","first-page":"2427","DOI":"10.3390\/microorganisms11102427","article-title":"Vector-Transmitted Flaviviruses: An Antiviral Molecules Overview","volume":"11","author":"Diani","year":"2023","journal-title":"Microorganisms."},{"key":"10.1016\/j.bioorg.2024.107914_b0150","doi-asserted-by":"crossref","first-page":"1371","DOI":"10.1080\/22221751.2022.2071175","article-title":"Virus-host interaction networks as new antiviral drug targets for IAV and SARS-CoV-2, Emerg","volume":"11","author":"Chen","year":"2022","journal-title":"Microbes Infect."},{"key":"10.1016\/j.bioorg.2024.107914_b0155","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1016\/j.drudis.2020.11.014","article-title":"Integrating molecular modelling methods to advance influenza A virus drug discovery","volume":"26","author":"Patel","year":"2021","journal-title":"Drug Discov. Today"},{"key":"10.1016\/j.bioorg.2024.107914_b0160","doi-asserted-by":"crossref","first-page":"776","DOI":"10.3390\/v15030776","article-title":"Host Cell Targets for Unconventional Antivirals against RNA Viruses","volume":"15","author":"Roa-Linares","year":"2023","journal-title":"Viruses"},{"key":"10.1016\/j.bioorg.2024.107914_b0165","doi-asserted-by":"crossref","first-page":"2391","DOI":"10.1002\/cmdc.202000464","article-title":"Broad-Spectrum Flavivirus Inhibitors: a Medicinal Chemistry Point of View","volume":"15","author":"Felicetti","year":"2020","journal-title":"ChemMedChem"},{"key":"10.1016\/j.bioorg.2024.107914_b0170","doi-asserted-by":"crossref","first-page":"398","DOI":"10.3389\/fcimb.2018.00398","article-title":"Cellular Targets for the Treatment of Flavivirus Infections","volume":"8","author":"Zakaria","year":"2018","journal-title":"Front. Cell. Infect. Microbiol."},{"key":"10.1016\/j.bioorg.2024.107914_b0175","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1128\/AAC.01429-12","article-title":"A novel inhibitor of dengue virus replication that targets the capsid protein","volume":"57","author":"Byrd","year":"2013","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.bioorg.2024.107914_b0180","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1007\/s12250-013-3390-x","article-title":"The flavivirus protease as a target for drug discovery","volume":"28","author":"Brecher","year":"2013","journal-title":"Virol. Sin."},{"key":"10.1016\/j.bioorg.2024.107914_b0185","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1016\/j.antiviral.2008.08.004","article-title":"Molecular targets for flavivirus drug discovery","volume":"81","author":"Sampath","year":"2009","journal-title":"Antiviral Res."},{"key":"10.1016\/j.bioorg.2024.107914_b0190","doi-asserted-by":"crossref","first-page":"44","DOI":"10.3390\/v14010044","article-title":"Potential Role of Flavivirus NS2B-NS3 Proteases in Viral Pathogenesis and Anti-flavivirus Drug Discovery Employing Animal Cells and Models: A Review","volume":"14","author":"Wahaab","year":"2022","journal-title":"Viruses"},{"key":"10.1016\/j.bioorg.2024.107914_b0195","doi-asserted-by":"crossref","first-page":"1271","DOI":"10.1016\/S1473-3099(14)70834-5","article-title":"Dengue and Dengue Vectors in the WHO European Region: Past, Present, and Scenarios for the Future","volume":"14","author":"Schaffner","year":"2014","journal-title":"Lancet Infect. Dis."},{"key":"10.1016\/j.bioorg.2024.107914_b0200","doi-asserted-by":"crossref","first-page":"2467","DOI":"10.1128\/jvi.65.5.2467-2475.1991","article-title":"Both nonstructural proteins NS2B and NS3 are required for the proteolytic processing of dengue virus nonstructural proteins","volume":"65","author":"Falgout","year":"1991","journal-title":"J. Virol."},{"key":"10.1016\/j.bioorg.2024.107914_b0205","doi-asserted-by":"crossref","first-page":"3108","DOI":"10.1128\/JVI.73.4.3108-3116.1999","article-title":"The serine protease and RNA-stimulated nucleoside triphosphatase and RNA helicase functional domains of dengue virus type 2 NS3 converge within a region of 20 amino acids","volume":"73","author":"Li","year":"1999","journal-title":"J. Virol."},{"key":"10.1016\/j.bioorg.2024.107914_b0210","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1016\/j.virol.2004.07.004","article-title":"The RNA helicase, nucleotide 5'-triphosphatase, and RNA 5'-triphosphatase activities of Dengue virus protein NS3 are Mg2+-dependent and require a functional Walker B motif in the helicase catalytic core","volume":"328","author":"Benarroch","year":"2004","journal-title":"Virology"},{"key":"10.1016\/j.bioorg.2024.107914_b0215","doi-asserted-by":"crossref","unstructured":"H. Norshidah, C.H. Leow, K.E. Ezleen, H.A. Wahab, R. Vignesh, A. Rasul, N.S. Lai, Assessing the potential of NS2B\/NS3 protease inhibitors biomarker in curbing dengue virus infections: In silico vs. In vitro approach, Front. Cell. Infect. Microbiol. 13 (2023) 1061937, https:\/\/doi.org\/10.3389\/fcimb.2023.1061937.","DOI":"10.3389\/fcimb.2023.1061937"},{"key":"10.1016\/j.bioorg.2024.107914_b0220","first-page":"1","article-title":"Organization of the Flavivirus RNA replicase complex, Wiley Interdiscip Rev","volume":"8","author":"Brand","year":"2017","journal-title":"RNA"},{"key":"10.1016\/j.bioorg.2024.107914_b0225","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1128\/JVI.01788-07","article-title":"Crystal structure of the NS3 protease-helicase from dengue virus","volume":"82","author":"Luo","year":"2008","journal-title":"J. Virol."},{"key":"10.1016\/j.bioorg.2024.107914_b0230","unstructured":"B.D. Lindenbach, H.J. Thiel, C.M. Rice, Flaviviridae: theviruses and their replication. In: Knipe DM, HowleyPM, eds.Fields Virology 5th ed. Philadelphia, PA:Lippincott-Raven Publishers (2007) 1101-1152."},{"key":"10.1016\/j.bioorg.2024.107914_b0235","doi-asserted-by":"crossref","first-page":"8898","DOI":"10.1073\/pnas.87.22.8898","article-title":"Evidence that the N-terminal domain of nonstructural protein NS3from yellow fever virus is a serine protease responsible for site-specific cleavages in the viral polyprotein","volume":"87","author":"Chambers","year":"1990","journal-title":"Proc. Natl. Acad. Sci."},{"key":"10.1016\/j.bioorg.2024.107914_b0240","doi-asserted-by":"crossref","first-page":"4364","DOI":"10.1128\/jvi.64.9.4364-4374.1990","article-title":"In vitro proces-sing of dengue virus type 2 nonstructural proteinsNS2A, NS2B, and NS3","volume":"64","author":"Preugschat","year":"1990","journal-title":"J. Virol."},{"key":"10.1016\/j.bioorg.2024.107914_b0245","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1099\/0022-1317-72-4-851","article-title":"In vitro synthesis of West Nile virus proteins indicatesthat the amino-terminal segment of the NS3 protein contains the active centre of the protease which cleaves the viral polyprotein after multiple basicamino acids","volume":"72","author":"Wengler","year":"1991","journal-title":"J. Gen. Virol."},{"key":"10.1016\/j.bioorg.2024.107914_b0250","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1016\/j.antiviral.2015.03.014","article-title":"The flavivirus NS2B-NS3 protease-helicase as a target for antiviral drug development","volume":"118","author":"Luo","year":"2015","journal-title":"Antiviral Res."},{"key":"10.1016\/j.bioorg.2024.107914_b0255","doi-asserted-by":"crossref","DOI":"10.1016\/j.antiviral.2020.104731","article-title":"Profiling of flaviviral NS2B-NS3 protease specificity provides a structural basis for the development of selective chemical tools that differentiate Dengue from Zika and West Nile viruses","volume":"175","author":"Rut","year":"2020","journal-title":"Antiviral Res."},{"key":"10.1016\/j.bioorg.2024.107914_b0260","doi-asserted-by":"crossref","first-page":"3108","DOI":"10.1128\/JVI.73.4.3108-3116.1999","article-title":"The serine protease and RNA-stimulated nucleosidet riphosphatase and RNA helicase functional domainsof dengue virus type 2 NS3 converge within a region of 20 amino acids","volume":"73","author":"Li","year":"1999","journal-title":"J. Virol."},{"key":"10.1016\/j.bioorg.2024.107914_b0265","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1016\/S0014-5793(99)01705-6","article-title":"Identification and characterization of the RNA helicase activity of Japanese encephalitis virus NS3 protein","volume":"465","author":"Utama","year":"2000","journal-title":"FEBS Lett."},{"key":"10.1016\/j.bioorg.2024.107914_b0270","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1007\/BF01702653","article-title":"Japanese encephalitis virus nonstructural protein NS3 has RNA binding and ATPase activities","volume":"9","author":"Takegami","year":"1995","journal-title":"Virus Genes"},{"key":"10.1016\/j.bioorg.2024.107914_b0275","doi-asserted-by":"crossref","first-page":"989","DOI":"10.1128\/jvi.67.2.989-996.1993","article-title":"RNA-stimulated NTPase activity associated with yellow fever virusNS3 protein expressed in bacteria","volume":"67","author":"Warrener","year":"1993","journal-title":"J. Virol."},{"key":"10.1016\/j.bioorg.2024.107914_b0280","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1016\/0042-6822(91)90440-M","article-title":"The carboxy-terminal part of the NS3 protein of the West Nile Flavivirus can be isolated as a soluble protein after proteolytic cleavageand represents an RNA-stimulated NTPase","volume":"184","author":"Wengler","year":"1991","journal-title":"Virology"},{"key":"10.1016\/j.bioorg.2024.107914_b0285","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1006\/viro.2002.1504","article-title":"Expression, purification, and characterization of the RNA 5\u2019-triphosphatase activity of dengue virus type 2 non-structural protein 3","volume":"299","author":"Bartelma","year":"2002","journal-title":"Virology"},{"key":"10.1016\/j.bioorg.2024.107914_b0290","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1006\/viro.1993.1587","article-title":"The NS 3 nonstructural protein offlaviviruses contains an RNA triphosphataseactivity","volume":"197","author":"Wengler","year":"1993","journal-title":"Virology"},{"key":"10.1016\/j.bioorg.2024.107914_b0295","doi-asserted-by":"crossref","first-page":"6797","DOI":"10.1128\/jvi.67.11.6797-6807.1993","article-title":"Mutagenesis of the yellow fever virus NS2B protein: effects on proteolytic processing, NS2B-NS3 complex formation, and viral replication","volume":"67","author":"Chambers","year":"1993","journal-title":"J. Virol."},{"key":"10.1016\/j.bioorg.2024.107914_b0300","doi-asserted-by":"crossref","first-page":"1403","DOI":"10.1099\/vir.0.80427-0","article-title":"Yellow fever virus NS2B-NS3 protease: characterization of charged-to-alanine mutant and revertant viruses and analysis of polyprotein-cleavage activities","volume":"86","author":"Chambers","year":"2005","journal-title":"J. Gen. Virol."},{"key":"10.1016\/j.bioorg.2024.107914_b0305","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1038\/nsmb1073","article-title":"Structural basis for the activation of flaviviral NS3 proteases from dengue and West Nile virus","volume":"13","author":"Erbel","year":"2006","journal-title":"Nat. Struct. Mol. Biol."},{"key":"10.1016\/j.bioorg.2024.107914_b0310","doi-asserted-by":"crossref","first-page":"6042","DOI":"10.1128\/jvi.65.11.6042-6050.1991","article-title":"Processing of the yellow fever virus nonstructural polyprotein: a catalytically active NS3 proteinase domain and NS2B are required for cleavages at dibasic sites","volume":"65","author":"Chambers","year":"1991","journal-title":"J. Virol."},{"key":"10.1016\/j.bioorg.2024.107914_b0315","doi-asserted-by":"crossref","first-page":"8362","DOI":"10.1128\/JVI.00814-06","article-title":"West Nile virus 50-cap structure is formed by sequential guanine N-7and ribose 20-O methylations by nonstructural protein 5","volume":"80","author":"Ray","year":"2006","journal-title":"J. Virol."},{"key":"10.1016\/j.bioorg.2024.107914_b0320","doi-asserted-by":"crossref","first-page":"2340","DOI":"10.1261\/rna.1609709","article-title":"The Flavivirus NS5 protein is a true RNA guanylyltransferase that catalyzes a two-step reaction to form the RNA cap structure","volume":"15","author":"Issur","year":"2009","journal-title":"RNA"},{"key":"10.1016\/j.bioorg.2024.107914_b0325","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/S0166-0934(00)00270-6","article-title":"Expression and purification of enzymatically active recombinant RNA-dependent RNA polymerase (NS5) of the Flavi-virus Kunjin","volume":"92","author":"Guyatt","year":"2001","journal-title":"J. Virol. Methods"},{"key":"10.1016\/j.bioorg.2024.107914_b0330","doi-asserted-by":"crossref","first-page":"4609","DOI":"10.1128\/JVI.02424-12","article-title":"Mem-brane topology and function of dengue virus NS2A protein","volume":"87","author":"Xie","year":"2013","journal-title":"J. Virol."},{"key":"10.1016\/j.bioorg.2024.107914_b0335","first-page":"2244","article-title":"Membrane topology of NS2B of dengue virus revealed by NMR spectroscopy","volume":"2015","author":"Li","year":"1848","journal-title":"BBA"},{"key":"10.1016\/j.bioorg.2024.107914_b0340","doi-asserted-by":"crossref","first-page":"8873","DOI":"10.1074\/jbc.M609919200","article-title":"The non-structural protein 4A of dengue virus is an integral membrane protein inducing membrane alterations in a 2K-regulated manner","volume":"282","author":"Miller","year":"2007","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bioorg.2024.107914_b0345","doi-asserted-by":"crossref","first-page":"8854","DOI":"10.1074\/jbc.M512697200","article-title":"Subcellular localization and membrane topology of the dengue virus type 2 non-structural protein 4B","volume":"281","author":"Miller","year":"2006","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bioorg.2024.107914_b0350","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1110\/ps.072753207","article-title":"Structural evidence for regulation and specificity of flaviviral proteases and evolution of the Flaviviridae fold","volume":"16","author":"Aleshin","year":"2007","journal-title":"Protein Sci."},{"key":"10.1016\/j.bioorg.2024.107914_b0355","doi-asserted-by":"crossref","first-page":"2081","DOI":"10.1099\/vir.0.012864-0","article-title":"NS4A regulates the ATPase activity of the NS3 helicase: a novel cofactor role of the non-structural protein NS4A from West Nile virus","volume":"90","author":"Shiryaev","year":"2009","journal-title":"J. Gen. Virol."},{"key":"10.1016\/j.bioorg.2024.107914_b0360","doi-asserted-by":"crossref","first-page":"2605","DOI":"10.1099\/vir.0.81844-0","article-title":"Dengue virus NS4B interacts with NS3 and dissociates it from single-stranded RNA","volume":"87","author":"Umareddy","year":"2006","journal-title":"J. Gen. Virol."},{"key":"10.1016\/j.bioorg.2024.107914_b0365","doi-asserted-by":"crossref","first-page":"3471","DOI":"10.1128\/JVI.03454-14","article-title":"Mapping the interactions between the NS4B and NS3 proteins of dengue virus","volume":"89","author":"Zou","year":"2015","journal-title":"J. Virol."},{"key":"10.1016\/j.bioorg.2024.107914_b0370","doi-asserted-by":"crossref","first-page":"14333","DOI":"10.1073\/pnas.2335168100","article-title":"Inhibition of interferon signaling by dengue virus","volume":"100","author":"Mu\u00f1oz-Jord\u00e1n","year":"2003","journal-title":"Proc. Natl. Acad. Sci."},{"key":"10.1016\/j.bioorg.2024.107914_b0375","doi-asserted-by":"crossref","first-page":"4623","DOI":"10.1128\/JVI.80.9.4623-4632.2006","article-title":"Regulated cleavages at the West Nile virus NS4A-2K-NS4B junctions play a major role in rearranging cytoplasmic membranes and golgi trafficking of the NS4A protein","volume":"80","author":"Roosendaal","year":"2006","journal-title":"J. Virol."},{"key":"10.1016\/j.bioorg.2024.107914_b0380","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1006\/viro.1996.0307","article-title":"Immunolocali-zation of the dengue virus nonstructural glycoproteinNS1 suggests a role in viral RNA replication","volume":"220","author":"Mackenzie","year":"1996","journal-title":"Virology"},{"key":"10.1016\/j.bioorg.2024.107914_b0385","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1016\/j.bbrc.2017.02.035","article-title":"Structure and sequence based functional annotation of Zika virus NS2B protein: Computational insights","volume":"492","author":"Aguilera-Pesantes","year":"2017","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.bioorg.2024.107914_b0390","doi-asserted-by":"crossref","first-page":"18817","DOI":"10.1074\/jbc.M109.090936","article-title":"Flexibility between the protease and helicase domainsof the dengue virus NS3 protein conferred by the linker region and its functional implications","volume":"285","author":"Luo","year":"2010","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bioorg.2024.107914_b0395","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1016\/j.jmb.2007.06.055","article-title":"Crystal structure andactivity of Kunjin virus NS3 helicase; protease andhelicase domain assembly in the full length NS3 protein","volume":"372","author":"Mastrangelo","year":"2007","journal-title":"J. Mol. Biol."},{"key":"10.1016\/j.bioorg.2024.107914_b0400","doi-asserted-by":"crossref","first-page":"10278","DOI":"10.1128\/JVI.79.16.10278-10288.2005","article-title":"Structure of the dengue virus helicase\/nucleoside triphosphatase cata-lytic domain at a resolution of 2.4 \u00c5","volume":"79","author":"Xu","year":"2005","journal-title":"J. Virol."},{"key":"10.1016\/j.bioorg.2024.107914_b0405","doi-asserted-by":"crossref","first-page":"6686","DOI":"10.1128\/JVI.02215-05","article-title":"Structure-based mutational analysis of the NS3 helicase from dengue virus","volume":"80","author":"Sampath","year":"2006","journal-title":"J. Virol."},{"key":"10.1016\/j.bioorg.2024.107914_b0410","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1002\/0470058005.ch7","article-title":"Towards the design of Flavivirus helicase\/NTPase inhibitors: crystallographic and mutagenesis studies of the dengue virus NS3 helicase catalytic domain","volume":"277","author":"Xu","year":"2006","journal-title":"Novartis Found. Symp."},{"key":"10.1016\/j.bioorg.2024.107914_b0415","doi-asserted-by":"crossref","first-page":"12895","DOI":"10.1128\/JVI.00942-09","article-title":"Crystal structure of a novel conformational state of the Flavivirus NS3 protein: implications for poly-protein processing and viral replication","volume":"83","author":"Assenberg","year":"2009","journal-title":"J. Virol."},{"key":"10.1016\/j.bioorg.2024.107914_b0420","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1016\/j.jmgm.2015.05.008","article-title":"Binding specificity of polypeptide substrates in NS2B\/NS3pro serine protease of dengue virus type 2: a molecular dynamics study","volume":"60","author":"Yotmanee","year":"2015","journal-title":"J. Mol. Graph. Model."},{"key":"10.1016\/j.bioorg.2024.107914_b0425","doi-asserted-by":"crossref","first-page":"4501","DOI":"10.1021\/cr000033x","article-title":"Serine protease mechanism and specificity","volume":"102","author":"Hedstrom","year":"2002","journal-title":"Chem. Rev."},{"key":"10.1016\/j.bioorg.2024.107914_b0430","doi-asserted-by":"crossref","first-page":"3629","DOI":"10.1021\/bi00435a001","article-title":"How do serine proteases really work?","volume":"28","author":"Warshel","year":"1989","journal-title":"Biochemistry"},{"key":"10.1016\/j.bioorg.2024.107914_b0435","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/j.antiviral.2012.09.007","article-title":"Structural biology of dengue virus enzymes: towards rational design of therapeutics","volume":"96","author":"Noble","year":"2012","journal-title":"Antiviral Res."},{"key":"10.1016\/j.bioorg.2024.107914_b0440","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.antiviral.2018.10.006","article-title":"Structures of Zika virus NS2B-NS3 protease in complex with peptidomimetic inhibitors","volume":"160","author":"Phoo","year":"2018","journal-title":"Antiviral Res."},{"key":"10.1016\/j.bioorg.2024.107914_b0445","doi-asserted-by":"crossref","unstructured":"M. Yildiz, S. Ghosh, J.A. Bell, W. Sherman, J.A. Hardy, Allosteric inhibition of the NS2B-NS3 protease from dengue virus, ACS Chem. Biol. 8 (2-13) 2744-2752. https:\/\/doi.org\/10.1021\/cb400612h.","DOI":"10.1021\/cb400612h"},{"key":"10.1016\/j.bioorg.2024.107914_b0450","doi-asserted-by":"crossref","first-page":"945","DOI":"10.1021\/acs.jcim.1c01326","article-title":"Characterization of an Allosteric Pocket in Zika Virus NS2B-NS3 Protease","volume":"62","author":"Santos","year":"2022","journal-title":"J. Chem. Inf. Model."},{"key":"10.1016\/j.bioorg.2024.107914_b0455","doi-asserted-by":"crossref","first-page":"876","DOI":"10.1039\/D0MD00154F","article-title":"Covalent inhibitors: a rational approach to drug discovery","volume":"11","author":"Sutanto","year":"2020","journal-title":"RSC Med. Chem."},{"key":"10.1016\/j.bioorg.2024.107914_b0460","doi-asserted-by":"crossref","first-page":"1046","DOI":"10.1038\/cr.2017.88","article-title":"Existing drugs as broad-spectrum and potent inhibitors for Zika virus by targeting NS2B-NS3 interaction","volume":"27","author":"Li","year":"2017","journal-title":"Cell Res."},{"key":"10.1016\/j.bioorg.2024.107914_b0465","doi-asserted-by":"crossref","first-page":"881","DOI":"10.1038\/s41573-022-00542-z","article-title":"Advances in covalent drug discovery","volume":"21","author":"Boike","year":"2022","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.bioorg.2024.107914_b0470","doi-asserted-by":"crossref","first-page":"663","DOI":"10.3390\/ph16050663","article-title":"Recent Advances in Covalent Drug Discovery","volume":"16","author":"Schaefer","year":"2023","journal-title":"Pharmaceuticals"},{"key":"10.1016\/j.bioorg.2024.107914_b0475","doi-asserted-by":"crossref","first-page":"10313","DOI":"10.1002\/anie.201502142","article-title":"Covalent-Allosteric Kinase Inhibitors","volume":"54","author":"Weisner","year":"2015","journal-title":"Angew. Chem."},{"key":"10.1016\/j.bioorg.2024.107914_b0480","doi-asserted-by":"crossref","first-page":"2617","DOI":"10.1039\/C9CS00720B","article-title":"Advances in covalent kinase inhibitors","volume":"49","author":"Abdeldayem","year":"2020","journal-title":"Chem. Soc. Rev."},{"key":"10.1016\/j.bioorg.2024.107914_b0485","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1016\/j.bmcl.2005.09.062","article-title":"Peptide inhibitors of Dengue virus NS3 protease. Part 1: Warhead","volume":"16","author":"Yin","year":"2006","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"10.1016\/j.bioorg.2024.107914_b0490","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1021\/acs.jmedchem.6b01021","article-title":"Peptide-Boronic Acid Inhibitors of Flaviviral Proteases: Medicinal Chemistry and Structural Biology","volume":"60","author":"Nitsche","year":"2017","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.bioorg.2024.107914_b0495","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1007\/s12551-019-00508-3","article-title":"Proteases from dengue, West Nile and Zika viruses as drug targets","volume":"11","author":"Nitsche","year":"2019","journal-title":"Biophys. Rev."},{"key":"10.1016\/j.bioorg.2024.107914_b0500","unstructured":"Pan American Health Organization (PAHO), Dengue. https:\/\/www.paho.org\/pt\/topicos\/dengue#:\u223c:text=Cerca%20de%20500%20milh%C3%B5es%20de,na%20d%C3%A9cada%20de%202010%2D2019. (Accessed 4 February 2024)."},{"key":"10.1016\/j.bioorg.2024.107914_b0505","unstructured":"World Health Organization (WHO), Dengue \u2013 Global situation. https:\/\/www.who.int\/emergencies\/disease-outbreak-news\/item\/2023-DON498. (Accessed 4 February 2024)."},{"key":"10.1016\/j.bioorg.2024.107914_b0510","unstructured":"Centers for Disease Control and Prevention (CDC), Dengue. https:\/\/www.cdc.gov\/dengue\/index.html. (Accessed 4 February 2024)."},{"key":"10.1016\/j.bioorg.2024.107914_b0515","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1590\/0074-0276140304","article-title":"Updating the geographical distribution and frequency of Aedes albopictus in Brazil with remarks regarding its range in the Americas","volume":"109","author":"Carvalho","year":"2014","journal-title":"Mem. Inst. Oswaldo Cruz"},{"key":"10.1016\/j.bioorg.2024.107914_b0520","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1007\/s00239-001-0064-3","article-title":"Rates of Molecular Evolution in RNA Viruses: A Quantitative Phylogenetic Analysis","volume":"54","author":"Jenkins","year":"2002","journal-title":"J. Mol. Evol."},{"key":"10.1016\/j.bioorg.2024.107914_b0525","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1093\/oxfordjournals.bmb.a011708","article-title":"Molecular epidemiology and evolution of emerging infectious diseases","volume":"54","author":"Holmes","year":"1998","journal-title":"Br. Med. Bull."},{"key":"10.1016\/j.bioorg.2024.107914_b0530","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1111\/j.1574-695X.2000.tb01474.x","article-title":"Cytokine cascade in dengue hemorrhagic fever: implications for pathogenesis","volume":"28","author":"Chaturvedi","year":"2000","journal-title":"FEMS Immunol. Med. Microbiol."},{"key":"10.1016\/j.bioorg.2024.107914_b0535","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1007\/978-981-10-8727-1_23","article-title":"Loock, An Industry Perspective on Dengue Drug Discovery and Development","volume":"1062","author":"Hernandez-Morales","year":"2018","journal-title":"Adv. Exp. Med. Biol."},{"key":"10.1016\/j.bioorg.2024.107914_b0540","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1056\/NEJMoa1800820","article-title":"Effect of dengue serostatus on dengue vaccine safety and efficacy","volume":"379","author":"Sridhar","year":"2018","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.bioorg.2024.107914_b0545","doi-asserted-by":"crossref","first-page":"1033","DOI":"10.1126\/science.aaf9590","article-title":"Benefits and risks of the Sanofi-Pasteur dengue vaccine: modeling optimal deployment","volume":"353","author":"Ferguson","year":"2016","journal-title":"Science"},{"key":"10.1016\/j.bioorg.2024.107914_b0550","doi-asserted-by":"crossref","first-page":"3910","DOI":"10.1016\/j.vaccine.2017.06.004","article-title":"ADE and dengue vaccination","volume":"35","author":"Mart\u00ednez-Vega","year":"2017","journal-title":"Vaccine"},{"key":"10.1016\/j.bioorg.2024.107914_b0555","first-page":"168","article-title":"Management of Dengue: An Updated Review, Indian","volume":"90","author":"Tayal","year":"2023","journal-title":"J. Pediatr."},{"key":"10.1016\/j.bioorg.2024.107914_b0560","doi-asserted-by":"crossref","first-page":"9","DOI":"10.7861\/clinmed.2021-0791","article-title":"Dengue infection: Global importance, immunopathology and management","volume":"22","author":"Kularatne","year":"2022","journal-title":"Clin. Med. (Lond.)"},{"key":"10.1016\/j.bioorg.2024.107914_b0565","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1016\/j.ejmech.2016.09.063","article-title":"Identification of fused bicyclic derivatives of pyrrolidine and imidazolidinone as dengue virus-2 NS2B-NS3 protease inhibitors","volume":"125","author":"Weng","year":"2017","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.bioorg.2024.107914_b0570","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1016\/j.bbrc.2022.08.060","article-title":"Discovery of highly potent DENV NS2B-NS3 covalent inhibitors containing a phenoxymethylphenyl residue","volume":"627","author":"Cheng","year":"2022","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.bioorg.2024.107914_b0575","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2022.114585","article-title":"Discovery of potent benzoxaborole inhibitors against SARS-CoV-2 main and dengue virus proteases","volume":"240","author":"K\u00fchl","year":"2022","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.bioorg.2024.107914_b0580","doi-asserted-by":"crossref","first-page":"6344","DOI":"10.1016\/j.bmc.2014.09.057","article-title":"Identification of novel thiadiazoloacrylamide analogues as inhibitors of dengue-2 virus NS2B\/NS3 protease","volume":"22","author":"Liu","year":"2014","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.bioorg.2024.107914_b0585","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1371\/journal.pone.0210869","article-title":"Thioguanine-based DENV-2 NS2B\/NS3 protease inhibitors: Virtual screening, synthesis, biological evaluation and molecular modelling","volume":"14","author":"Hariono","year":"2019","journal-title":"PLoS One"},{"key":"10.1016\/j.bioorg.2024.107914_b0590","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1002\/ardp.202300292","article-title":"Repurposing of investigational cancer drugs: Early phase discovery of dengue virus NS2B\/NS3 protease inhibitors","volume":"356","author":"Saleem","year":"2023","journal-title":"Arch. Pharm."},{"key":"10.1016\/j.bioorg.2024.107914_b0595","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1371\/journal.pone.0233993","article-title":"A cell-based high-throughput screen identifies inhibitors that overcome P-glycoprotein (Pgp)-mediated multidrug resistance","volume":"15","author":"Zahra","year":"2020","journal-title":"PLoS One"},{"key":"10.1016\/j.bioorg.2024.107914_b0600","first-page":"843","article-title":"Design, Synthesis, and in-vitro Protease Inhibition Assay of Linear Pentapeptides as Potential Dengue Virus NS2B\/NS3 Protease Inhibitors","volume":"77","author":"Abdalrazaq","year":"2022","journal-title":"Arch. Razi Inst."},{"key":"10.1016\/j.bioorg.2024.107914_b0605","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2023.115227","article-title":"N-sulfonyl peptide-hybrids as a new class of dengue virus protease inhibitors","volume":"251","author":"Behrouz","year":"2023","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.bioorg.2024.107914_b0610","doi-asserted-by":"crossref","first-page":"21646","DOI":"10.1038\/s41598-022-25836-5","article-title":"Design, synthesis, in vitro, in silico, and SAR studies of favone analogs towards anti\u2013dengue activity","volume":"12","author":"Patigo","year":"2022","journal-title":"Sci. Rep."},{"key":"10.1016\/j.bioorg.2024.107914_b0615","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1016\/j.bmc.2014.12.015","article-title":"Flavonoids as noncompetitive inhibitors of Dengue virus NS2B-NS3 protease: Inhibition kinetics and docking studies","volume":"23","author":"de Sousa","year":"2015","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.bioorg.2024.107914_b0620","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1016\/j.antiviral.2015.03.010","article-title":"Antiviral activities of 15 dengue NS2B-NS3 protease inhibitors using a human cell-based viral quantification assay","volume":"118","author":"Chu","year":"2015","journal-title":"Antiviral Res."},{"key":"10.1016\/j.bioorg.2024.107914_b0625","doi-asserted-by":"crossref","first-page":"79","DOI":"10.47665\/tb.38.2.044","article-title":"Natural DENV-2 NS2B\/NS3 protease inhibitors from Myristica cinnamomea King","volume":"38","author":"Sivasothy","year":"2021","journal-title":"Trop. Biomed."},{"key":"10.1016\/j.bioorg.2024.107914_b0630","doi-asserted-by":"crossref","first-page":"329","DOI":"10.15585\/mmwr.mm6612a4","article-title":"Zika Virus Transmission - Region of the Americas","volume":"66","author":"Ikejezie","year":"2017","journal-title":"MMWR Morb. Mortal. Wkly Rep."},{"key":"10.1016\/j.bioorg.2024.107914_b0635","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1016\/S1473-3099(17)30727-2","article-title":"Association Between Microcephaly, Zika Virus Infection, and Other Risk Factors in Brazil: Final Report of a Casecontrol Study","volume":"18","author":"de Araujo","year":"2018","journal-title":"Lancet Infect. Dis."},{"key":"10.1016\/j.bioorg.2024.107914_b0640","unstructured":"Centers for Disease Control and Prevention (CDC), Zika virus https:\/\/www.cdc.gov\/zika\/index.html. (Accessed 5 February 2024)."},{"key":"10.1016\/j.bioorg.2024.107914_b0645","unstructured":"Pan American Health Organization (PAHO), Zika. https:\/\/www.paho.org\/en\/topics\/zika. (Accessed 5 February 2024)."},{"key":"10.1016\/j.bioorg.2024.107914_b0650","unstructured":"World Health Organization (WHO), Zika virus. https:\/\/www.who.int\/news-room\/fact-sheets\/detail\/zika-virus. (Accessed 5 February 2024)."},{"key":"10.1016\/j.bioorg.2024.107914_b0655","doi-asserted-by":"crossref","unstructured":"J.A. Bernatchez, L.T. Tran, J. Li, Y. Luan, J.L. Siqueira-Neto, R. Li, Drugs for the treatment of zika virus infection, J. Med. Chem. 63 (2020) 470e489, https:\/\/doi.org\/10.1021\/acs.jmedchem.9b00775.","DOI":"10.1021\/acs.jmedchem.9b00775"},{"key":"10.1016\/j.bioorg.2024.107914_b0660","doi-asserted-by":"crossref","DOI":"10.1016\/j.bioorg.2022.106269","article-title":"Allosteric quinoxaline-based inhibitors of the flavivirus NS2B\/NS3 protease","volume":"131","author":"Zephyr","year":"2023","journal-title":"Bioorg. Chem."},{"key":"10.1016\/j.bioorg.2024.107914_b0665","doi-asserted-by":"crossref","first-page":"1106","DOI":"10.3390\/v15051106","article-title":"Allosteric Inhibitors of Zika Virus NS2B-NS3 Protease Targeting Protease in \u201cSuper-Open\u201d Conformation","volume":"15","author":"Meewan","year":"2023","journal-title":"Viruses"},{"key":"10.1016\/j.bioorg.2024.107914_b0670","doi-asserted-by":"crossref","first-page":"1100","DOI":"10.1128\/AAC.03543-14","article-title":"Novel dengue virus NS2B\/NS3 protease inhibitors","volume":"59","author":"Wu","year":"2015","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.bioorg.2024.107914_b0675","doi-asserted-by":"crossref","first-page":"11359","DOI":"10.1021\/acs.jmedchem.9b01697","article-title":"Proline-Based Allosteric Inhibitors of Zika and Dengue Virus NS2B\/NS3 Proteases","volume":"62","author":"Millies","year":"2019","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.bioorg.2024.107914_b0680","doi-asserted-by":"crossref","DOI":"10.1016\/j.bmc.2021.116392","article-title":"SAR of novel benzothiazoles targeting an allosteric pocket of DENV and ZIKV NS2B\/NS3 proteases","volume":"47","author":"Maus","year":"2021","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.bioorg.2024.107914_b0685","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2021.113767","article-title":"Synthesis, Structure-Activity Relationship and Antiviral Activity of Indole-Containing Inhibitors of Flavivirus NS2B-NS3 protease","volume":"225","author":"Nie","year":"2021","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.bioorg.2024.107914_b0690","doi-asserted-by":"crossref","first-page":"2777","DOI":"10.1021\/acs.jmedchem.0c02070","article-title":"Synthesis, Structure\u2212Activity Relationships, and Antiviral Activity of Allosteric Inhibitors of Flavivirus NS2B\u2212NS3 Protease","volume":"64","author":"Nie","year":"2021","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.bioorg.2024.107914_b0695","doi-asserted-by":"crossref","DOI":"10.1016\/j.virusres.2023.199092","article-title":"Development of NS2B-NS3 protease inhibitor that impairs Zika virus replication","volume":"329","author":"Lin","year":"2023","journal-title":"Virus Res."},{"key":"10.1016\/j.bioorg.2024.107914_b0700","article-title":"The discovery of Zika virus NS2B-NS3 inhibitors with antiviral activity via an integrated virtual screening approach","volume":"175","author":"Mirza","year":"2022","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.bioorg.2024.107914_b0705","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/j.antiviral.2016.12.016","article-title":"Identification of novel small molecule inhibitors against NS2B\/NS3 serine protease from Zika virus","volume":"139","author":"Lee","year":"2017","journal-title":"Antiviral Res."},{"key":"10.1016\/j.bioorg.2024.107914_b0710","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1016\/j.antiviral.2017.04.015","volume":"143","author":"Shiryaev","year":"2017","journal-title":"Antiviral Res."},{"key":"10.1016\/j.bioorg.2024.107914_b0715","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/j.biochi.2023.04.004","article-title":"Identification of novel Zika virus NS3 protease inhibitors with different inhibition modes by integrative experimental and computational approaches","volume":"212","author":"Andrade","year":"2023","journal-title":"Biochimie"},{"key":"10.1016\/j.bioorg.2024.107914_b0720","doi-asserted-by":"crossref","DOI":"10.1016\/j.antiviral.2022.105255","article-title":"Identification of a small compound that specifically inhibits Zika virus in vitro and in vivo by targeting the NS2B-NS3 protease","volume":"199","author":"Miao","year":"2022","journal-title":"Antiviral Res."},{"key":"10.1016\/j.bioorg.2024.107914_b0725","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1021\/acs.jcim.9b00933","article-title":"Identification of Zika Virus NS2B-NS3 Protease Inhibitors by Structure-Based Virtual Screening and Drug Repurposing Approaches","volume":"60","author":"Santos","year":"2020","journal-title":"J. Chem.Inform. Model."},{"key":"10.1016\/j.bioorg.2024.107914_b0730","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/j.antiviral.2017.07.007","article-title":"Structure-based discovery of clinically approved drugs as Zika virus NS2B-NS3 protease inhibitors that potently inhibit Zika virus infection in vitro and in vivo","volume":"145","author":"Yuan","year":"2017","journal-title":"Antiviral Res."},{"key":"10.1016\/j.bioorg.2024.107914_b0735","doi-asserted-by":"crossref","first-page":"6555","DOI":"10.1021\/acs.jmedchem.1c01860","article-title":"Structure-Based Optimization and Characterization of Macrocyclic Zika Virus NS2B-NS3 Protease Inhibitors","volume":"65","author":"Huber","year":"2022","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.bioorg.2024.107914_b0740","doi-asserted-by":"crossref","first-page":"1439","DOI":"10.1002\/cmdc.202000237","article-title":"Structure-Based Macrocyclization of Substrate Analogue NS2B-NS3 Protease Inhibitors of Zika, West Nile and Dengue viruses","volume":"15","author":"Braun","year":"2020","journal-title":"ChemMedChem"},{"key":"10.1016\/j.bioorg.2024.107914_b0745","article-title":"SAR evolution towards potent C-terminal carboxamide peptide inhibitors of Zika virus NS2B-NS3 protease","volume":"57","author":"Calarusso","year":"2022","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.bioorg.2024.107914_b0750","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1007\/s10529-016-2261-6","article-title":"Inhibitory effect of flavonoids against NS2B-NS3 protease of ZIKA virus and their structure activity relationship","volume":"39","author":"Lim","year":"2017","journal-title":"Biotec. Letters"},{"key":"10.1016\/j.bioorg.2024.107914_b0755","doi-asserted-by":"crossref","first-page":"e0180632","DOI":"10.1371\/journal.pone.0180632","article-title":"Solution conformations of Zika NS2B-NS3pro and its inhibition by natural products from edible plants","volume":"12","author":"Roy","year":"2017","journal-title":"PLoS One"},{"key":"10.1016\/j.bioorg.2024.107914_b0760","doi-asserted-by":"crossref","unstructured":"C.S. Lima, M. Mottin, L.R. de Assis, N.C.M.R. Mesquita, B.K.P. Sousa, L.D. Coimbra, K. Bispo-dos- Santos, K.M. Zorn, R.V.C. Guido, S. Ekins, R.E. Marques, J.L. Proen\u00e7a-Modena, G. Oliva, C.H. Andrade, L.O. Regasini, Flavonoids from Pterogyne nitens as Zika virus NS2B-NS3 protease inhibitors, Bioorg. Chem. 109 (2021) 104719, https:\/\/doi:10.1016\/j.bioorg.2021.104719.","DOI":"10.1016\/j.bioorg.2021.104719"},{"key":"10.1016\/j.bioorg.2024.107914_b0765","doi-asserted-by":"crossref","first-page":"e0010819","DOI":"10.1371\/journal.pntd.0010819","article-title":"Host selection and forage ratio in West Nile virus\u2013transmitting Culex mosquitoes: Challenges and knowledge gaps","volume":"16","author":"Riccetti","year":"2022","journal-title":"PLoS Negl. Trop. Dis."},{"key":"10.1016\/j.bioorg.2024.107914_b0770","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1016\/j.cois.2017.05.002","article-title":"West Nile virus and its vectors","volume":"22","author":"Ciota","year":"2017","journal-title":"Curr. Opin. Insect Sci."},{"key":"10.1016\/j.bioorg.2024.107914_b0775","doi-asserted-by":"crossref","first-page":"1475","DOI":"10.1093\/jme\/tjz146","article-title":"West Nile Virus Mosquito Vectors in North America","volume":"56","author":"Rochlin","year":"2019","journal-title":"J. Med. Entomol."},{"key":"10.1016\/j.bioorg.2024.107914_b0780","doi-asserted-by":"crossref","unstructured":"N. Assaid, L. Mousson, S. Moutailler, S. Arich, K. Akarid, M. Monier, C. Beck, S. Lecollinet, A.B. Failloux, M. Sarih, Evidence of circulation of West Nile virus in Culex pipiens mosquitoes and horses in Morocco, 205 (2020) 105414, https:\/\/doi.org\/10.1016\/j.actatropica.2020.105414.","DOI":"10.1016\/j.actatropica.2020.105414"},{"key":"10.1016\/j.bioorg.2024.107914_b0785","doi-asserted-by":"crossref","first-page":"720","DOI":"10.3390\/v12070720","article-title":"West Nile Virus in Slovenia","volume":"12","author":"Knap","year":"2020","journal-title":"Viruses"},{"key":"10.1016\/j.bioorg.2024.107914_b0790","first-page":"233","article-title":"West Nile virus and other mosquito-borne viruses present in Eastern Europe, Pathog","volume":"112","author":"Napp","year":"2018","journal-title":"Glob Health"},{"key":"10.1016\/j.bioorg.2024.107914_b0795","doi-asserted-by":"crossref","DOI":"10.1016\/j.actatropica.2022.106391","article-title":"Detection and molecular characterization of West Nile virus in Culex pipiens mosquitoes in Central Macedonia, Greece, 2019\u2013202","volume":"230","author":"Tsioka","year":"2022","journal-title":"Acta Trop."},{"key":"10.1016\/j.bioorg.2024.107914_b0800","doi-asserted-by":"crossref","first-page":"148","DOI":"10.2987\/22-7074","article-title":"West Nile Virus Surveillance in Sentinel Chickens and Mosquitoes in Panama City Beach, Florida, from 2014 to 2020","volume":"38","author":"Riles","year":"2022","journal-title":"J. Am. Mosq. Control Assoc."},{"key":"10.1016\/j.bioorg.2024.107914_b0805","doi-asserted-by":"crossref","first-page":"1343","DOI":"10.1111\/tmi.12935","article-title":"West Nile Virus lineage-2 in Culex specimens from Iran","volume":"22","author":"Shahhosseini","year":"2017","journal-title":"Trop. Med. Int. Health"},{"key":"10.1016\/j.bioorg.2024.107914_b0810","doi-asserted-by":"crossref","DOI":"10.1016\/j.actatropica.2022.106720","article-title":"Replication and transmission of West Nile virus in simulated overwintering adults of Culex pipiens pallens (Diptera: Culicidae) in China","volume":"237","author":"Jiang","year":"2023","journal-title":"Acta Trop."},{"key":"10.1016\/j.bioorg.2024.107914_b0815","doi-asserted-by":"crossref","first-page":"225","DOI":"10.4103\/0972-9062.374039","article-title":"West Nile virus in India: An update on its genetic lineages","volume":"60","author":"Rajaiah","year":"2023","journal-title":"J. Vector Brone Dis."},{"key":"10.1016\/j.bioorg.2024.107914_b0820","unstructured":"Pan American Health Organization (PAHO), Arboviral Encephalitis https:\/\/www.paho.org\/en\/topics\/arboviral-encephalitis. (Accessed 5 February 2024)."},{"key":"10.1016\/j.bioorg.2024.107914_b0825","unstructured":"Centers for Disease Control and Prevention (CDC), West Nile Virus https:\/\/www.cdc.gov\/westnile\/index.html. (Accessed 5 February 2024)."},{"key":"10.1016\/j.bioorg.2024.107914_b0830","unstructured":"World Health Organization (WHO), West Nile virus. https:\/\/www.who.int\/news-room\/fact-sheets\/detail\/west-nile-virus. (Accessed 5 February 2024)."},{"key":"10.1016\/j.bioorg.2024.107914_b0835","doi-asserted-by":"crossref","first-page":"e0223017","DOI":"10.1371\/journal.pone.0223017","article-title":"Discovery of novel West Nile Virus protease inhibitor based on isobenzonafuranone and triazolic derivatives of eugenol and indan-1,3-dione scaffolds","volume":"14","author":"de Oliveira","year":"2019","journal-title":"PLoS One"},{"key":"10.1016\/j.bioorg.2024.107914_b0840","doi-asserted-by":"crossref","first-page":"5748","DOI":"10.1016\/j.bmc.2015.07.012","article-title":"Dual inhibitors of the dengue and West Nile virus NS2B\u2013NS3 proteases: Synthesis, biological evaluation and docking studies of novel peptide-hybrids","volume":"23","author":"Lima","year":"2015","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.bioorg.2024.107914_b0845","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1080\/14756366.2018.1506772","article-title":"Phosphonate inhibitors of West Nile virus NS2B\/NS3 protease","volume":"34","author":"Skore\u0144ski","year":"2019","journal-title":"J. Enzyme Inhib. Med. Chem."},{"key":"10.1016\/j.bioorg.2024.107914_b0850","unstructured":"pkCSM - pharmacokinetics, pkCSM: predicting small-molecule pharmacokinetic properties using graph-based signatures https:\/\/biosig.lab.uq.edu.au\/pkcsm\/. (Accessed 5 February 2024)."},{"key":"10.1016\/j.bioorg.2024.107914_b0855","doi-asserted-by":"crossref","first-page":"881","DOI":"10.1038\/nrd2445","article-title":"The influence of drug-like concepts on decision making in medicinal chemistry","volume":"6","author":"Leeson","year":"2007","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.bioorg.2024.107914_b0860","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1016\/S1461-5347(98)00097-2","article-title":"Physical chemical properties of oral drug candidates in the discovery and exploratory development settings","volume":"1","author":"Curatolo","year":"1998","journal-title":"Pharmaceut. Sci. Technol. Today"},{"key":"10.1016\/j.bioorg.2024.107914_b0865","doi-asserted-by":"crossref","first-page":"1224","DOI":"10.1021\/mp300537k","article-title":"In silico physico chemical parameter predictions","volume":"10","author":"Wenlock","year":"2013","journal-title":"Mol. Pharm."},{"key":"10.1016\/j.bioorg.2024.107914_b0870","doi-asserted-by":"crossref","first-page":"1497","DOI":"10.1016\/S1359-6446(05)03584-1","article-title":"Computing chemistry on the web","volume":"10","author":"Tetko","year":"2005","journal-title":"Drug Discov. Today"},{"key":"10.1016\/j.bioorg.2024.107914_b0875","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/S0169-409X(96)00423-1","article-title":"Experimental and computational approaches to estimate solubility and permeability in drug discovery and developmental settings","volume":"23","author":"Lipinski","year":"1997","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.bioorg.2024.107914_b0880","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/S0169-409X(00)00129-0","article-title":"Experimental and computational approaches to estimate solubility and permeability in discovery and development Settings","volume":"46","author":"Lipinski","year":"2001","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.bioorg.2024.107914_b0885","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1517\/17460441003605098","article-title":"Lipophilicity in drug discovery","volume":"5","author":"Waring","year":"2010","journal-title":"Expet Opin. Drug Discov."},{"key":"10.1016\/j.bioorg.2024.107914_b0890","doi-asserted-by":"crossref","first-page":"1789","DOI":"10.1021\/jm301514n","article-title":"Contributions of molecular properties to drug promiscuity","volume":"56","author":"Tarcsay","year":"2013","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.bioorg.2024.107914_b0895","unstructured":"Clinical Trials.gov, National Institutes of Health (NIH), National Library of Medicine https:\/\/classic.clinicaltrials.gov\/ct2\/results?cond=flavivirus&term=&cntry=&state=&city=&dist= (Accessed 5 February 2024)."},{"key":"10.1016\/j.bioorg.2024.107914_b0900","doi-asserted-by":"crossref","first-page":"596","DOI":"10.1590\/S0074-02762013000500010","article-title":"Chloroquine use improves dengue-related symptoms","volume":"108","author":"Borges","year":"2013","journal-title":"Mem. Inst. Oswaldo Cruz"},{"key":"10.1016\/j.bioorg.2024.107914_b0905","doi-asserted-by":"crossref","first-page":"1442","DOI":"10.1093\/infdis\/jis470","article-title":"A randomized, double-blind placebo controlled trial of balapiravir, a polymerase inhibitor, in adult dengue patients","volume":"207","author":"Nguyen","year":"2013","journal-title":"J Infect Dis"},{"key":"10.1016\/j.bioorg.2024.107914_b0910","doi-asserted-by":"crossref","first-page":"678","DOI":"10.1038\/s41586-023-05790-6","article-title":"Blocking NS3\u2013NS4B interaction inhibits dengue virus in non-human primates","volume":"615","author":"Goethals","year":"2023","journal-title":"Nature"},{"key":"10.1016\/j.bioorg.2024.107914_b0915","unstructured":"Clinical Trials.gov, National Institutes of Health (NIH), National Library of Medicine, A Study of JNJ-64281802 in Participants With Confirmed Dengue Fever https:\/\/clinicaltrials.gov\/study\/NCT04906980?tab=results#publications (Accessed 5 February 2024)."},{"key":"10.1016\/j.bioorg.2024.107914_b0920","doi-asserted-by":"crossref","first-page":"4063","DOI":"10.1021\/acs.jmedchem.3c02336","article-title":"Discovery of JNJ-1802, a First-in-Class Pan-Serotype Dengue Virus NS4B Inhibitor","volume":"67","author":"Kesteleyn","year":"2024","journal-title":"J. Med. Chem."}],"container-title":["Bioorganic Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0045206824008198?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0045206824008198?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,1,30]],"date-time":"2025-01-30T02:27:51Z","timestamp":1738204071000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0045206824008198"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,12]]},"references-count":184,"alternative-id":["S0045206824008198"],"URL":"https:\/\/doi.org\/10.1016\/j.bioorg.2024.107914","relation":{},"ISSN":["0045-2068"],"issn-type":[{"value":"0045-2068","type":"print"}],"subject":[],"published":{"date-parts":[[2024,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Advances in drug discovery of flavivirus NS2B-NS3pro serine protease inhibitors for the treatment of Dengue, Zika, and West Nile viruses","name":"articletitle","label":"Article Title"},{"value":"Bioorganic Chemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bioorg.2024.107914","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"107914"}}